FierceBiotech2d
GSK offers up to £50M to conduct cancer vaccine research with the University of Oxford
British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...
GSK strikes deal with Oxford for cancer jabs
The company said under a collaboration with the university it would invest £50m over three years to find out whether cancers ...
New solar farm near Barnard Castle to power GSK factory for 40 years
The new facility at Stainton, near Barnard Castle, will power the nearby Glaxo Smith Kline factory for 40 years ...
GSK, Oxford to establish GSK-Oxford Cancer Immuno-Prevention Programme
GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...
GlaxoSmithKline: Sell Rating Amidst Weak Vaccine Performance and Projected EPS Decline
GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from ...
FierceBiotech14d
JPM25: GSK’s CSO shares science strategy behind deal-heavy year
And while Wood said the pharma still isn’t interested in joining the overcrowded obesity landscape, GSK is considering ways to build past the GLP-1 space.
Goodwin Enlisted for $1.15 Billion GSK Acquisition of US Biopharma Business
A Goodwin Procter team has advised on British pharmaceutical giant GSK’s $1.15 billion acquisition of a US biopharmaceutical ...
pharmaphorum9d
GSK names Burberry's Julie Brown as its new CFO
GSK has said that its chief financial officer ... having previously held roles at UK drugmaker AstraZeneca and medical device player Smith & Nephew, as well as serving as a non-executive director ...
Leprosy Treatment Market Set To Witness Significant Growth By 2024-2031 Glaxo Smithcline Pharmaceuticals Ltd.
Leprosy treatment Market. BURLINGAME, CA, UNITED STATES, January 13, 2025 /EINPresswire / -- This report on the Leprosy Treatment market offers an comprehe ...